MicrobiologybioRxiv
Development of SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibodies
J. S. Terry, L. B. Anderson, M. S. Scherman…·B. J. Geiss
This study develops and characterizes mouse monoclonal antibodies specific to SARS-CoV-2 nucleocapsid protein, tested using ELISA, western blot, and immunofluorescence.
DOI 10.1016/j.virol.2021.01.003